Diabetes remission was achieved in 44 and 28% of patients in the dapagliflozin and placebo groups, respectively. HealthDay News — For patients with overweight or obesity and type 2 diabetes ...

Diabetes remission was achieved in 44% and 28% of patients in the dapagliflozin and placebo groups, respectively, over 12 months, meeting the predefined primary end point. Yuejun Liu, from Fudan ...

(HealthDay News) — For patients with overweight or obesity and type 2 diabetes, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes ...

For this study, researchers focused on the SGLT-2 drug dapagliflozin, and how it worked in combination with a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit ...